High Grade B Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Treated with DA-EPOCH-R Induction and Nivolumab Consolidation Treatment: Interim Results of the HOVON-152 Phase II Trial

Blood(2021)

Cited 0|Views6
No score
Abstract
Introduction
More
Translated text
Key words
cell lymphoma,bcl6 rearrangements,bcl2,nivolumab consolidation treatment,myc,da-epoch-r
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined